title: Clonal polymorphism of Borrelia burgdorferi strain B31 MI: implications for mutagenesis in an infectious strain background.
abstract: A major obstacle to studying the functions of particular gene products in the mouse-tick infectious cycle of Borrelia burgdorferi has been an inability to knock out genes in pathogenic strains. Here, we investigated conditions for site-directed mutagenesis in B31 MI, the low-passage-number, infectious B. burgdorferi strain whose genome was sequenced. We inactivated several plasmid and chromosomal genes in B31 MI and determined that clones carrying these mutations were not infectious for mice. However, we found extensive heterogeneity among clones and mutants derived from B31 MI based on colony phenotype, growth rate, plasmid content, protein profile, and transformability. Significantly, several B31 MI clones that were not subjected to mutagenesis but that lacked particular plasmids also exhibited defects at various stages in the infectious cycle. Therefore, the high degree of clonal polymorphism within B31 MI complicates the assessment of the contributions of individual genes to the observed phenotypes of the mutants. Our results indicate that B31 MI is not an appropriate strain background for genetic studies in infectious B. burgdorferi, and a well-defined isogenic clone is a prerequisite for targeted mutagenesis. To this end, we derived several wild-type clones from B31 MI that were infectious for mice, and gene inactivation was successful in one of these clones. Due to the instability of the genome with in vitro propagation, careful monitoring of plasmid content of derived mutants and complementation of inactivated genes will be crucial components of genetic studies with this pathogen.
authors.affiliation: Laboratory of Human Bacterial Pathogenesis, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana 59840, USA. abdallah.elias@charite.de
authors.forename: Abdallah F
authors.initials: AF
authors.lastname: Elias
authors.forename: Philip E
authors.initials: PE
authors.lastname: Stewart
authors.forename: Dorothee
authors.initials: D
authors.lastname: Grimm
authors.forename: Melissa J
authors.initials: MJ
authors.lastname: Caimano
authors.forename: Christian H
authors.initials: CH
authors.lastname: Eggers
authors.forename: Kit
authors.initials: K
authors.lastname: Tilly
authors.forename: James L
authors.initials: JL
authors.lastname: Bono
authors.forename: Darrin R
authors.initials: DR
authors.lastname: Akins
authors.forename: Justin D
authors.initials: JD
authors.lastname: Radolf
authors.forename: Tom G
authors.initials: TG
authors.lastname: Schwan
authors.forename: Patricia
authors.initials: P
authors.lastname: Rosa
mesh_terms: D000222:Adaptation, Physiological; D000818:Animals; D000954:Antigens, Surface / Q000235:genetics; D001425:Bacterial Outer Membrane Proteins / Q000235:genetics; D001428:Bacterial Vaccines; D025065:Borrelia burgdorferi / Q000235:genetics* / Q000254:growth & development / Q000472:pathogenicity; D008074:Lipoproteins; D016296:Mutagenesis; D011110:Polymorphism, Genetic; D011817:Rabbits; D013696:Temperature; D013987:Ticks / Q000382:microbiology; D014169:Transformation, Bacterial
chemical_list: D000954:Antigens, Surface; D001425:Bacterial Outer Membrane Proteins; D001428:Bacterial Vaccines; D008074:Lipoproteins; C072045:OspA protein